|
|
|
|
|
| November 17, 2011 | ISSUE NUMBER 226 VOL 8 |
|
Legal
Supreme Court to Rule on Health Reform Legality
The US Supreme Court, as expected, is set to decide if key provisions of the Obama administration’s health care overhaul law violate the Constitution by exceeding the federal government’s power to regulate interstate commerce and to levy taxes. Justices indicated that they will hear oral arguments in March 2012, which would lead to a ruling on the case in June, just four months prior to the November presidential elections ...Read More
Safety
Drug 'Fact Box' Quiz: You Decide
A growing body of academic literature — and FDA’s Risk Communication and Advisory Committee — suggests that drug fact boxes would help doctors and consumers evaluate new drugs more effectively, that is to say, scientifically. Do you agree? Take the quiz to find out ...Read More
Regulatory
Patients and Payers: Aligning the Incentives
Pharmaceutical and biotechnology companies need to demonstrate innovation and differentiation as they launch new products to market. Patients are at the center of this debate as they want to be more empowered in their search for quality care and informed of alternatives for potential treatment. The creation of the US-based Patient-Centered Outcomes Research Institute (PCORI) aims to embody this new patient role ...Read More
Global
Recognizing 'Real Innovation': An IMI Update
There is a risk that the currency of terms like ‘innovation’ has been devalued by over-use. But one organization at least has come a little closer to matching words with deeds. Europe’s grandly titled Innovative Medicines Initiative (IMI) last month provided an overview of some of its achievements—and some of them merit recognition ...Read more
| Advertisement |
| |
 |
| |
|
A Pragmatist's Guide To Building A Business Case For ERP
Leveraging survey results from her firm’s 2011 ERP Solution Study, Cindy Jutras, a leading enterprise analyst, offers practical advice in building one’s business case for a formula-based ERP application, including top operational goals, key performance expectations, ROI timeline and cloud vs on-premise platform decision.
 Read White Paper |
Online
Read the Latest Pharm Exec Global Digest
Features this month cover recruitment in the era of lean; new horizons for biopharm outsourcing; optimizing market access efforts; and the ongoing information to patients debate in Europe ...Read more
|
|
|
 // Catalyst Pharmaceutical Partners, Inc. (Coral Gables, Fla.) announced the appointment of Richard P. Rieger as Vice President, Commercial Operations.
// Heptares Therapeutics (Boston, Mass.) appointed Daniel Grau as President.// Catalent Pharma Solutions, Inc. (Somerset, NJ) announced the appointment of Jonathan Arnold as Vice President and General Manager, Sterile Technologies.// Andrew J. Schulman became President, Marketing, for AccentHealth (New York, NY).// Oncolytics Biotech Inc. (Calgary, Alberta, Canada) appointed Gerard Kennealey, MD, as Senior Vice President of Clinical Development and Chief Medical Officer.
|
|
|
|
|
|
|
|
 |
|
 |
| |
 |
 |
|
 |
| Which country do you think will offer the most significant growth prospects over the next 3 years? |
|
|
|
|
You
are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To
ensure delivery to your Inbox, please add us to your
address book. If you need help doing this, click
here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
